Lucira Health, Inc. (“Lucira Health” or “Lucira”) (Nasdaq: LHDX), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, today announced that the company will be participating in the BofA Securities 2021 Virtual Healthcare Conference.

Lucira Health’s management is scheduled to participate in the conference on Thursday, May 13, 2021, at 9:30 a.m. PT / 12:30 p.m. ET. A live and archived webcast of the event can be accessed via the Investors page of the investor section of Lucira's website.

About Lucira Health

Lucira Health is a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits. Lucira’s testing platform produces lab quality molecular testing in a single-use, consumer-friendly, palm size test kit powered by two AA batteries. Lucira designed its test kits to provide accurate, reliable and on-the-spot molecular tests results anywhere and anytime. The LUCIRA CHECK IT (OTC) and LUCIRA COVID-19 All-In-One Test Kits (RX) are designed to provide a clinically relevant COVID-19 result within 30 minutes from sample collection. For more information, visit www.lucirahealth.com.

Investor Contact
Greg Chodaczek
This email address is being protected from spambots. You need JavaScript enabled to view it.
347-620-7010

Media Contact
Kevin Knight
This email address is being protected from spambots. You need JavaScript enabled to view it.
206-451-4823